HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Budesonide enema in pouchitis--a double-blind, double-dummy, controlled trial.

AbstractBACKGROUND:
Pouchitis has been suggested to be a recurrence of ulcerative colitis in a colon-like mucosa. Topical steroids are a valid therapeutic alternative for distal forms of ulcerative colitis.
AIM:
To investigate the efficacy and tolerability of budesonide enema in the treatment of pouchitis compared with oral metronidazole.
MATERIALS AND METHODS:
Twenty-six patients with an active episode of pouchitis (defined as a pouchitis disease activity index score >or= 7) and no treatment during the previous month were randomized to receive either budesonide enema (2 mg/100 mL at bedtime) plus placebo tablets or oral metronidazole (0.5 g b.d.) plus placebo enema in a prospective, double-blind, double-dummy, 6-week, controlled trial.
RESULTS:
Based on the intention-to-treat principle, we detected a significant improvement in disease activity at the end of the first week with both drugs (P < 0.01). After that, improvement was moderated until stabilization at 4 weeks in both treatments. The per protocol analysis showed that both drugs had similar efficacy in terms of disease activity, clinical and endoscopic findings. Fifty-eight per cent and 50% of patients improved (decrease in pouchitis disease activity index >or= 3) with budesonide enema and metronidazole, respectively (odds ratio, 1.4; confidence interval, 0.2-8.9). Adverse effects were observed in 57% of patients given metronidazole and in 25% of patients given budesonide.
CONCLUSIONS:
Budesonide enemas are an alternative treatment for active pouchitis, with similar efficacy but better tolerability than oral metronidazole.
AuthorsA Sambuelli, L Boerr, S Negreira, A Gil, G Camartino, S Huernos, Z Kogan, A Cabanne, A Graziano, H Peredo, I Doldán, O Gonzalez, E Sugai, M Lumi, J C Bai
JournalAlimentary pharmacology & therapeutics (Aliment Pharmacol Ther) Vol. 16 Issue 1 Pg. 27-34 (Jan 2002) ISSN: 0269-2813 [Print] England
PMID11856075 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Infective Agents
  • Anti-Inflammatory Agents
  • Metronidazole
  • Budesonide
Topics
  • Administration, Oral
  • Adolescent
  • Adult
  • Anti-Infective Agents (administration & dosage, adverse effects, pharmacology)
  • Anti-Inflammatory Agents (administration & dosage, adverse effects, pharmacology)
  • Budesonide (administration & dosage, adverse effects, pharmacology)
  • Double-Blind Method
  • Enema
  • Female
  • Humans
  • Male
  • Metronidazole (administration & dosage, adverse effects, pharmacology)
  • Middle Aged
  • Pouchitis (drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: